A recent study in Molecular Psychiatry delves into the genetic architecture of schizophrenia, uncovering insights into common and rare genetic variants, treatment resistance, and the
A recent study explores the potential benefits of utilizing duck fats in the food industry, highlighting their unique fatty acid composition and improved properties compared
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter
A cancer cell therapy biotech that emerged just nine months ago with $200 million and a Phase I trial already underway will test the public
A newly unsealed lawsuit filed by activist investor Carl Icahn alleges that Illumina board members ignored antitrust regulators when buying Grail for $8 billion, failed
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit
MADRID — Immunotherapy, chemotherapy, and a PARP inhibitor in the first line improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, according
MADRID — The significant survival benefit with the bispecific T-cell receptor therapy tebentafusp (Kimmtrak) held up at 3 years for selected patients with previously untreated
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
WASHINGTON — All U.S. infants at birth should be automatically enrolled in public health coverage, and “universal eligibility” should be given up to age 26